Individual and simultaneous receptor antagonism improved endothelial repair of SSc-IgG-treated cells with significant scratch-area reduction (ATR-A, ATR-A/ETR-A; all P < 0.05, Figure 3B). This evidence concerns the gene EDNRA and systemic sclerosis.